Ebola and Marburg hemorrhagic fevers are acute viral diseases that often lead to severe illness and death in humans and other primates. The infections typically affect multiple organs in the body and are often accompanied by hemorrhage (bleeding). Once the virus has been transmitted from an animal host to a human, it can then spread through person-to-person contact. Researchers in the NIAID Division of Intramural Research and at the Institute’s Vaccine Research Center as well as NIAID-supported scientists in external facilities are studying all aspects of Ebola and Marburg viruses, how they spread, and how they cause disease. Investigators seek better ways to diagnose and treat Ebola and Marburg fevers, including promising work on vaccines.
Media Availability: Cancer Drug May Treat Sepsis, Other Uncontrollable Immune Responses to Infection—April 29, 2016
Media Availability: Two-Vaccine Ebola Regimen Shows Promise in Early-Stage Clinical Trial—April 19, 2016
Media Availability: NIH Doctors Describe Severe Case of Ebola Virus Disease—April 4, 2016
Media Availability: Experimental Ebola Antibody Protects Monkeys—Feb. 25, 2016
Media Availability: Experimental Ebola Vaccines Well Tolerated, Immunogenic in Phase 2 Study—Feb. 23, 2016
All Ebola and Marburg News Releases
Last Updated April 29, 2016